• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球范围内念珠菌菌株的 fks1 热点 1 突变低流行率。

Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.

机构信息

JMI Laboratories, North Liberty, IA 52317, USA.

出版信息

Antimicrob Agents Chemother. 2010 Jun;54(6):2655-9. doi: 10.1128/AAC.01711-09. Epub 2010 Apr 5.

DOI:10.1128/AAC.01711-09
PMID:20368396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2876398/
Abstract

We evaluated the prevalence of fks1 hot spot (HS) 1 mutations among 133 Candida strains from six species displaying various caspofungin MIC values (from < or =0.008 to >8 microg/ml). Only 4 (2.9%) strains displayed FKS1 HS1 amino acid substitutions: 1 C. albicans (F641Y) among 32 isolates tested (3.1%), 1 C. glabrata (S645P) among 34 isolates tested (2.9%), and 2 C. tropicalis (F641S) among 12 isolates tested (16.7%). The 4 isolates displaying FKS1 HS1 alterations showed elevated caspofungin MIC results (1 to >8 microg/ml) but lower anidulafungin and micafungin MIC values (0.12 to 4 microg/ml and 0.25 to 4 microg/ml, respectively) in some instances within the wild-type MIC population, as determined using the epidemiologic cutoff values (ECV). Candida krusei, C. parapsilosis, and C. guilliermondii isolates tested showed no FKS1 HS1 alterations regardless of echinocandin MIC result. We additionally analyzed 8 C. albicans and 7 C. glabrata strains for mutations on other HS regions of fks1 and fks2. Three C. glabrata strains showed alterations on FKS2 HS1 (two S645P and one L644W). In general, strains displaying S645P alteration showed higher echinocandin MIC values than strains harboring other mutations. Overall, Candida spp. strains showing caspofungin MIC values within the ECV did not display fks HS mutations. In contrast, strains showing alterations in this region displayed anidulafungin and/or micafungin MIC values within the wild-type population, suggesting that caspofungin could be the most sensitive agent for detection of these resistance mutations. Furthermore, results from this large, geographically diverse Candida spp. collection demonstrated that fks1 HS1 mutations remain uncommon among isolates with various echinocandin MIC levels.

摘要

我们评估了来自六个种属的 133 株念珠菌菌株中 fks1 热点(HS)1 突变的流行率,这些菌株的卡泊芬净 MIC 值(从 <=0.008 至 >8μg/ml)各不相同。仅有 4 株(2.9%)显示 FKS1 HS1 氨基酸取代:32 株受试菌株中的 1 株白念珠菌(F641Y)(3.1%),34 株受试菌株中的 1 株光滑念珠菌(S645P)(2.9%),以及 12 株受试菌株中的 2 株热带念珠菌(F641S)(16.7%)。4 株显示 FKS1 HS1 改变的菌株表现出卡泊芬净 MIC 结果升高(1 至 >8μg/ml),但在野生型 MIC 群体中,某些情况下,安尼芬净和米卡芬净 MIC 值较低(分别为 0.12 至 4μg/ml 和 0.25 至 4μg/ml),这是根据流行病学临界值(ECV)确定的。无论棘白菌素 MIC 结果如何,克柔念珠菌、近平滑念珠菌和季也蒙念珠菌的受试菌株均未显示 FKS1 HS1 改变。我们还分析了 8 株白念珠菌和 7 株光滑念珠菌菌株的其他 fks1 和 fks2 HS 区域的突变。3 株光滑念珠菌菌株显示 FKS2 HS1 改变(2 株 S645P 和 1 株 L644W)。一般来说,显示 S645P 改变的菌株比携带其他突变的菌株显示出棘白菌素 MIC 值更高。总的来说,显示卡泊芬净 MIC 值在 ECV 内的念珠菌属菌株未显示 fks HS 突变。相比之下,在野生型群体中显示该区域改变的菌株显示出安尼芬净和/或米卡芬净 MIC 值,表明卡泊芬净可能是检测这些耐药突变最敏感的药物。此外,来自这个具有地理多样性的大型念珠菌属菌株的结果表明,fks1 HS1 突变在具有各种棘白菌素 MIC 值的菌株中仍然很少见。

相似文献

1
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.全球范围内念珠菌菌株的 fks1 热点 1 突变低流行率。
Antimicrob Agents Chemother. 2010 Jun;54(6):2655-9. doi: 10.1128/AAC.01711-09. Epub 2010 Apr 5.
2
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
3
Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.白色念珠菌、热带念珠菌和克鲁斯念珠菌中fks1基因的突变,与采用欧洲抗生素敏感性试验委员会的方法在AM3培养基中发现的卡泊芬净最低抑菌浓度升高相关。
Antimicrob Agents Chemother. 2008 Sep;52(9):3092-8. doi: 10.1128/AAC.00088-08. Epub 2008 Jun 30.
4
Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.监测全球侵袭性酵母菌和霉菌中的抗真菌药物耐药性:CLSI 流行病学折点值的应用和全基因组测序分析在检测白念珠菌中唑类耐药性中的应用。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00906-17. Print 2017 Oct.
5
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.FKS 突变与美国基于人群监测的光滑念珠菌分离株中棘白菌素 MIC 值升高相关。
Antimicrob Agents Chemother. 2010 Dec;54(12):5042-7. doi: 10.1128/AAC.00836-10. Epub 2010 Sep 13.
6
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响:对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
7
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.棘白菌素类药物和念珠菌属的野生型 MIC 分布和流行病学折点值
J Clin Microbiol. 2010 Jan;48(1):52-6. doi: 10.1128/JCM.01590-09. Epub 2009 Nov 18.
8
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.棘白菌素类耐药性在光滑念珠菌中的增加:临床失败与 FKS 突变和最低抑菌浓度升高相关。
Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13.
9
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).Sensititre YeastOne 棘白菌素药敏试验流行病学折点用于鉴定 FKS 突变的白念珠菌和光滑念珠菌的准确性:瑞士真菌感染网络(FUNGINOS)的十年全国调查。
Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.
10
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).比较了棘白菌素类药物(阿尼芬净)与其他 9 种抗真菌药物对念珠菌属、隐球菌属和曲霉菌属的体外抗菌活性:全球 SENTRY 抗菌药物监测计划(2008 年)的结果。
J Clin Microbiol. 2010 Aug;48(8):2984-7. doi: 10.1128/JCM.00328-10. Epub 2010 Jun 9.

引用本文的文献

1
Increased fungal burden in the gastrointestinal tract of brain-dead organ donors.脑死亡器官捐献者胃肠道中真菌负荷增加。
Microbiol Spectr. 2025 Aug 5;13(8):e0334124. doi: 10.1128/spectrum.03341-24. Epub 2025 Jun 18.
2
Antifungal drug resistance in Candida glabrata: role of cellular signaling and gene regulatory networks.光滑念珠菌的抗真菌药物耐药性:细胞信号传导和基因调控网络的作用
FEMS Yeast Res. 2025 Jan 30;25. doi: 10.1093/femsyr/foaf025.
3
Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates.光滑念珠菌棘白菌素耐药系列分离株中FKS1和FKS2之间的热点基因转换
NPJ Antimicrob Resist. 2025 Apr 17;3(1):31. doi: 10.1038/s44259-025-00102-6.
4
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.超越传统抗真菌药物:通过新型治疗途径对抗耐药性。
Pharmaceuticals (Basel). 2025 Mar 4;18(3):364. doi: 10.3390/ph18030364.
5
: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen.一种主要机会性真菌病原体中的多药耐药性与毒力增强
Curr Fungal Infect Rep. 2012 Jun;6(3):154-164. doi: 10.1007/s12281-012-0091-0.
6
Anidulafungin is a useful surrogate marker for predicting susceptibility to rezafungin among five species using CLSI methods and interpretive criteria.使用CLSI方法和解释标准时,阿尼芬净是预测五种菌种对瑞扎芬净敏感性的有用替代标志物。
J Clin Microbiol. 2025 Feb 19;63(2):e0112924. doi: 10.1128/jcm.01129-24. Epub 2025 Jan 22.
7
Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins.调节卡泊芬净适应性突变体棘白菌素敏感性的基因在对棘白菌素具有中度或完全抗性的临床分离株中组成性表达。
J Fungi (Basel). 2024 Mar 19;10(3):224. doi: 10.3390/jof10030224.
8
Development of Echinocandin Resistance in : An Emergent, Widespread, and Opportunistic Fungal Pathogen.棘白菌素耐药性在(某真菌名称未给出)中的发展:一种新兴、广泛传播且具机会致病性的真菌病原体 。
J Fungi (Basel). 2023 Aug 18;9(8):859. doi: 10.3390/jof9080859.
9
Fluconazole and echinocandin resistance of species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.在 COVID-19 大流行之前和期间,大学医院侵袭性念珠菌病中 属的氟康唑和棘白菌素耐药性。
Epidemiol Infect. 2023 Aug 25;151:e146. doi: 10.1017/S0950268823001346.
10
Phytotherapy: A Solution to Decrease Antifungal Resistance in the Dental Field.植物疗法:降低牙科领域抗真菌耐药性的解决方案。
Biomolecules. 2022 Jun 4;12(6):789. doi: 10.3390/biom12060789.

本文引用的文献

1
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.棘白菌素类药物和念珠菌属的野生型 MIC 分布和流行病学折点值
J Clin Microbiol. 2010 Jan;48(1):52-6. doi: 10.1128/JCM.01590-09. Epub 2009 Nov 18.
2
Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).当代抗真菌药物(包括新型棘白菌素阿尼芬净)对念珠菌属、隐球菌属和曲霉属的活性:哨兵抗菌监测计划(2006年至2007年)报告
J Clin Microbiol. 2009 Jun;47(6):1942-6. doi: 10.1128/JCM.02434-08. Epub 2009 Apr 22.
3
Anidulafungin in the treatment of patients with invasive candidiasis.阿尼芬净治疗侵袭性念珠菌病患者
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S99-S102. doi: 10.1016/S0924-8579(08)70008-6.
4
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.白色念珠菌棘白菌素最低抑菌浓度(MIC)与fks1突变体葡聚糖合酶动力学抑制的相关性:对解释性断点的影响
Antimicrob Agents Chemother. 2009 Jan;53(1):112-22. doi: 10.1128/AAC.01162-08. Epub 2008 Oct 27.
5
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.焦磷酸测序法检测白色念珠菌中FKS1基因的突变,这些突变会导致对棘白菌素的敏感性降低。
Antimicrob Agents Chemother. 2008 Nov;52(11):4145-8. doi: 10.1128/AAC.00959-08. Epub 2008 Sep 15.
6
Treatment of invasive candidal infections: systematic review and meta-analysis.侵袭性念珠菌感染的治疗:系统评价与荟萃分析
Mayo Clin Proc. 2008 Sep;83(9):1011-21. doi: 10.4065/83.9.1011.
7
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.光滑念珠菌感染继发侵袭性念珠菌病长期治疗后卡泊芬净耐药性的产生。
Antimicrob Agents Chemother. 2008 Oct;52(10):3783-5. doi: 10.1128/AAC.00473-08. Epub 2008 Aug 1.
8
Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.白色念珠菌、热带念珠菌和克鲁斯念珠菌中fks1基因的突变,与采用欧洲抗生素敏感性试验委员会的方法在AM3培养基中发现的卡泊芬净最低抑菌浓度升高相关。
Antimicrob Agents Chemother. 2008 Sep;52(9):3092-8. doi: 10.1128/AAC.00088-08. Epub 2008 Jun 30.
9
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.近平滑念珠菌、正平滑念珠菌和副平滑念珠菌中Fks1p天然存在的脯氨酸到丙氨酸的氨基酸变化导致棘白菌素敏感性降低。
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.
10
Resistance to echinocandin-class antifungal drugs.对棘白菌素类抗真菌药物的耐药性。
Drug Resist Updat. 2007 Jun;10(3):121-30. doi: 10.1016/j.drup.2007.04.002. Epub 2007 Jun 13.